← All trials
NCT06858397
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 14, 2025
- Primary completion
- Aug 30, 2028
- Completion date
- Aug 30, 2028
- First posted
- Mar 5, 2025
- Last posted
- Nov 4, 2025
- Enrollment
- 18
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Green Cross CorporationLead sponsor
- Hanmi PharmaceuticalCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.